New blood test could catch deadly liver disease before It's too late

NCT ID NCT05880173

Summary

This study aims to find out if a new, automated way of using a common blood test (called FIB4) is a good method for screening the general population for advanced liver scarring (fibrosis). The goal is to identify people with serious liver damage early, before they develop life-threatening complications like cirrhosis or liver cancer. Researchers will enroll about 500 adults and follow a specific testing pathway to see if this screening approach is effective and worthwhile.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCREENING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Hospitalier de Lens

    RECRUITING

    Lens, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Chu Angers

    NOT_YET_RECRUITING

    Angers, 49000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Chu Bordeaux

    NOT_YET_RECRUITING

    Angers, 49000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Chu Grenoble Alpes

    RECRUITING

    Grenoble, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Chu Nancy

    RECRUITING

    Nancy, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hopital Saint Joseph

    NOT_YET_RECRUITING

    Marseille, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.